Discovery, Characterization, and Significance of the Cytochrome P450 ω‐Hydroxylase Pathway of Vitamin E Catabolism
- 1 December 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1031 (1) , 13-21
- https://doi.org/10.1196/annals.1331.002
Abstract
Tocopherols are known to undergo metabolism to phytyl chain-shortened metabolites excreted in urine. We sought to characterize the pathway, including associated enzymes, involved in this biotransformation. We previously found that human hepatoblastoma (HepG2) cultures metabolized tocopherols to their corresponding short-chain carboxychromanols. Putative metabolites of gamma-tocopherol that contained intact chromanol moieties were structurally identified using HepG2 cultures and electron impact gas chromatography-mass spectrometry. A microsomal assay for synthesis of the initial omega-oxidation metabolites was developed and used to screen several recombinant human liver cytochrome P450 isozymes for omega-hydroxylase activity. Seven metabolites of gamma-tocopherol were identified in HepG2 cultures, including 13'-hydroxy-gamma-TOH and all six carboxychromanols predicted by sequential omega-oxidation truncation. Rat and human liver microsomes catalyzed synthesis of 13'-OH- and 13'-COOH-gamma-TOH, but not other metabolites, in the presence of NADPH. Inclusion of NAD favored synthesis of the 13'-COOH metabolite. Recombinant CYP4F2, but not other major human liver CYP isoforms (including CYP3A4 and 3A7), exhibited tocopherol-omega-hydroxylase activity. Liver microsomes and recombinant CYP4F2 both exhibited substrate preference for gamma-TOH over alpha-TOH, and recent studies show that tocotrienols are catabolized more extensively than the corresponding tocopherols. Comparative rates of omega-oxidation of tocochromanols in hepatocytes are inversely related to biopotency and directly related to cytotoxicity of these substances in macrophages. The liver contains a cytochrome P450-mediated pathway that preferentially catabolizes "non-alpha" tocochromanols to excretable metabolites. This metabolic pathway appears central to the optimization of tissue tocochromanol status.Keywords
This publication has 12 references indexed in Scilit:
- Cereal Alkylresorcinols Elevate γ-Tocopherol Levels in Rats and Inhibit γ-Tocopherol Metabolism In VitroJournal of Nutrition, 2004
- Effects of Sesamin and Capsaicin on the mRNA Expressions of .DELTA.6 and .DELTA.5 Desaturases in Rat Primary Cultured HepatocytesJournal of Nutritional Science and Vitaminology, 2003
- Identities and Differences in the Metabolism of Tocotrienols and Tocopherols in HepG2 CellsJournal of Nutrition, 2002
- Prostaglandin and leukotriene ω-hydroxylasesProstaglandins & Other Lipid Mediators, 2002
- Cytochrome P450 ω-Hydroxylase Pathway of Tocopherol CatabolismJournal of Biological Chemistry, 2002
- Cytochrome P4503A-Dependent Metabolism of Tocopherols and Inhibition by SesaminBiochemical and Biophysical Research Communications, 2000
- A Novel 5′-Carboxychroman Metabolite of γ-Tocopherol Secreted by HepG2 Cells and Excreted in Human UrineBiochemical and Biophysical Research Communications, 2000
- Urinary excretion of 2,7,8-trimethyl-2-(β-carboxyethyl)-6-hydroxychroman is a major route of elimination of γ-tocopherol in humansJournal of Lipid Research, 1999
- Inhibition and induction of human cytochrome P450 (CYP) enzymesXenobiotica, 1998
- Sesamin is a potent and specific inhibitor of Δ5 desaturase in polyunsaturated fatty acid biosynthesisLipids, 1991